Clinical Trials Logo

Irritable Bowel Syndrome clinical trials

View clinical trials related to Irritable Bowel Syndrome.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06187298 Completed - Clinical trials for Irritable Bowel Syndrome

Effect of Oral Combined Berberine and Curcumin Pharmacological Therapy on IBS

Start date: August 25, 2020
Phase:
Study type: Observational

Irritable bowel syndrome (IBS) is a prevalent, chronic functional gastrointestinal (GI) disorder, characterized by recurrent abdominal discomfort (pain) associated with altered bowel movements. IBS has a considerable negative impact on people's quality of life (QoL). There is currently no specific treatment available for IBS; most of the therapeutic management is symptomatic. Reported evidence suggest that BBR and CUR can alleviate symptoms of IBS through their multiple pharmacological effects including preventing stress-induced intestinal inflammation and visceral hypersensitivity, reducing bowel motility, and regulating intestinal permeability, gut microme and gut-brain axis.

NCT ID: NCT06167018 Completed - Clinical trials for Irritable Bowel Syndrome

Nurse-administered, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS).

Start date: September 2005
Phase:
Study type: Observational

Adult IBS patients with symptoms refractory to standard medical treatment received nurse-administered, gut-directed hypnotherapy. The primary outcome measure was change in gastro-intestinal symptom severity.

NCT ID: NCT05978973 Completed - Clinical trials for Irritable Bowel Syndrome

Elemental Diet and Gut Microbiome

Start date: August 6, 2023
Phase: N/A
Study type: Interventional

he primary objective of this study is to assess changes in stool microbiome profiles in patients after an elemental diet.

NCT ID: NCT05947929 Completed - Clinical trials for Irritable Bowel Syndrome

Aerobic Exercise Verus Acupuncture on the Quality of Life in Women Suffering From Irritable Bowel Syndrome

Start date: May 20, 2021
Phase: N/A
Study type: Interventional

To compare the effect of aerobic exercise and the acupuncture on the quality of life in women with irritable bowel syndrome

NCT ID: NCT05931107 Completed - Depression Clinical Trials

Effect of Stress Ball on Irritable Bowel Syndrome

Start date: July 19, 2023
Phase: N/A
Study type: Interventional

Objective: This study will be conducted to evaluate the effect of stress ball on symptom severity, quality of life, depression, anxiety and stress in patients with irritable bowel syndrome (IBS). Material and Method: The data of the randomized controlled experimental study will be collected at the gastroenterology outpatient clinic of Erzurum City Hospital. A simple randomization list was created with the Random Allocation Software program and it will be carried out with a total of 56 patients diagnosed with IBS, including 28 experimental and 28 control groups. Patients in the experimental group were asked to squeeze the stress ball for at least 10 minutes every day for 4 weeks. No treatment will be applied to those in the control group. Patient information form, IBS symptom severity score, IBS quality of life scale, Depression-Anxiety-Stress scale will be used to collect research data. Keywords: Irritable Bowel Syndrome, patient, stress ball, Depression, Anxiety, Stress, Quality of Life

NCT ID: NCT05900752 Completed - Diarrhea Clinical Trials

A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients

Start date: June 19, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional clinical study is to study whether the consumption of QiMeiYan Probiotics in 25-35 young people with Mild irritable bowel syndrome (IBS Score 75 - 175) will reduce the frequency of Diarrhea. 140 eligible participants (70 males and 70 females) will be enrolled in two study sites and randomly assigned to two groups of products QiMeiYan Probiotics and placebo. All participants will consume assigned products once a day after meals and record the critical data such as photo of feces. Three site visits will be arranged and all clinical data will be captured and recorded into CTMS (Clinical Trial Management System) for statistical analysis. Researchers will compare the two groups to validate if the daily consumption of QiMeiYan Probiotics will reduce the frequency of Diarrhea in the study population.

NCT ID: NCT05867550 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea

Start date: January 3, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to compare the efficacy of four different drugs in combination for management of irritable bowel syndrome (IBS)-associated diarrhea. The main question to answer is: - Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea? Participants will be divided into 3 treatment groups. - Each group will be given a combination of drugs for 2 weeks - At the end of study, efficacy of different drug combinations and their potential side effects will be compared between the treatment groups

NCT ID: NCT05816681 Completed - Diarrhea Clinical Trials

Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

Start date: August 22, 2022
Phase: Phase 1
Study type: Interventional

This study aims to assess elemental impurities level after dministration of dioctahedral smectite in subjects with functional diarrhea or irritable bowel syndrome with predominant diarrhea. Male or female subjects aged between 19 and 60 years will participate in the study. The study design is an opne-label, randomized, multiple dose paraller study. The patients were randomly assigned to DWJ1230 or DWB2001. It is intended that a total of 60 subjects will be enrolled to ensure that at least 24 subjects will complete the study.

NCT ID: NCT05731232 Completed - Clinical trials for Irritable Bowel Syndrome

Effects of Vivatlac Synbiotikum in Patients With Irritable Bowel Syndrome

ViIBS
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

Multi-centre, randomized, double-blind, placebo-controlled trial investigating the effects of a nine-strain synbiotic (Vivatlac Synbiotikum) in IBS patients.

NCT ID: NCT05702255 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome

Start date: February 5, 2023
Phase: N/A
Study type: Interventional

This study aims to assess the effect of active self- administered acupressure compared to sham self- administered acupressure on the health outcome for patient with diarrhea predominant Irritable Bowel Syndrome